Elevated circulating total homocysteine (tHcy) concentrations are related to increased risk for cardiovascular disease.
Introduction
Since 1 January 1998, all processed cereals in the United States have been fortified with folic acid at the level of 140 mg/100 g of food (1) in response to the Public Health Service's recommendation that all women of child-bearing age should consume 400 mg/d of folic acid to reduce the risk of having a child with neural tube defect (2) . The actual increase in folic acid intake is more than the predicted intake of 100 mg/d (3, 4) , because several fortified foods contained higher amounts of folic acid than the FDA mandated (5) . There is a concern that some individuals may be consuming more folic acid than the upper intake level of 1000 mg/d (6) . Overall, folic acid fortification resulted in a significant improvement in serum folate concentrations (7) (8) (9) (10) (11) . After an initial dramatic increase in serum folate following folic acid fortification, the serum folate concentrations have recently modestly but significantly decreased (7, 8) due to the decreased intakes of folic acid (12) .
In addition to a reduction in neural tube defects (13) , one important benefit of mandated folic acid fortification is decreased total homocysteine (tHcy) 4 concentrations (7) (8) (9) 14) . Evidence from clinical and epidemiological studies suggests that elevated tHcy in the circulation is linked to increased risk for cardiovascular disease (CVD) (15, 16 ) and decreased cognitive function (17) and bone mineral density (18, 19) . It is not known whether increased circulating tHcy leads to the development of CVD or vice versa.
Homocysteine (Hcy) is a sulfur-containing, nonessential amino acid formed from the demethylation of methionine. Genetic abnormalities [methylenetetrahydrofolate reductase (MTHFR) polymorphism] (20, 21) and B vitamin deficiencies (22, 23) are important factors responsible for elevated tHcy concentrations. Hcy is either remethylated to methionine or trans-sulfurated to cysteine.
In remethylation, folate is required as a substrate, and riboflavin and cobalamin are required as coenzymes. In transsulfuration, pyridoxine is used as a coenzyme (24, 25) . Decreased circulating concentrations of folate, riboflavin, cobalamin, and pyridoxine are associated with increased serum tHcy concentration (26) (27) (28) , whereas increased B vitamin status is related to decreased tHcy (29) . Sex, race/ethnicity, and age are related to tHcy (26, 27, 30, 31) . Serum creatinine, a measure of renal function, and smoking are directly associated with serum tHcy (26, 27) . The association between tHcy and serum cotinine, a measure of cigarette smoking, BMI, and methylmalonic acid (MMA), a measure of cobalamin deficiency, has received little attention.
The majority of studies have focused on the determinants of tHcy based on the data collected during the pre-folic acid fortification period (26, 27, 32, 33) . Also, the majority of population studies on the determinants of tHcy have focused on folate. Because tHcy concentrations are significantly lower since the years after the folic acid fortification (7, 9, 14) , it is important to identify the determinants of tHcy concentrations in the postfolic acid fortification period. Therefore, the objective of this study was to investigate the relation between plasma tHcy concentrations and demographic, lifestyle, and health factors and concentrations of circulating B vitamins and MMA in the post-folic acid fortification period.
Materials and Methods
Survey description and study sample. The National Center for Health Statistics (NCHS) of the CDC conducts NHANES on civilian, noninstitutionalized residents of the US. NHANES were designed to be a complex, stratified, multistage probability sample survey. Demographic, socioeconomic, dietary, and health related data were collected in the participants' homes as part of the household interview. A physicianadministered examination was conducted with household interviewed persons in mobile examination centers (MEC). In NHANES, young children, older persons, non-Hispanic black (NHB), and Mexican American/Hispanic (MA/H) were oversampled to yield reliable estimates for these groups. Beginning in 1999, NHANES were conducted as continuous, annual surveys rather than the periodic surveys. The NHANES protocols were reviewed and approved by the NCHS Institutional Review Board and all individuals gave their informed consent prior to participation.
In this study, (10, 122 were home interviewed; 9643 were examined in MEC). The detailed description of survey methodologies and analytical guidelines has been described earlier (37) (38) (39) .
In the data analysis, pregnant women (n ¼ 760); individuals who reported their race/ethnicity as ''unknown'' or other than non-Hispanic white (NHW), NHB, or MA/H (n ¼ 642); and individuals with missing data for sex, race/ethnicity, age, BMI, systolic blood pressure (BP), diastolic BP, vitamin/mineral supplement use, RBC folate, and concentrations of serum creatinine, cotinine, folate, cobalamin, and MMA were excluded. After applying the above exclusion criteria, the study sample consisted of 16,254 subjects (8329 men and 7925 women).
Measurements. NCHS collected data on body measurements, demography, physical function, health condition, lifestyle behaviors, biochemical measurements of blood and urine, and diet intake depending on the age of the participant. Blood was collected from venipuncture in the MEC according to the standard protocols. Of 16,254 participants, ;62% (n ¼ 10,122) had fasted for $9 h and ;38% (n ¼ 6132) fasted for ,9 h. Data on the length of fasting was missing for 13 participants. Length of fasting had no measurable effect on the circulating tHcy (32) . Whole blood was collected into EDTA-treated tubes and centrifuged at 2900 3 g; 10 min at 4-8°C (V6500; Hamilton Bell) to yield plasma. Plasma tHcy concentrations were determined using an immunoassay (Abbott Imx for NHANES 1999-2001 and Abbott AxSym for NHANES 2002-2004; Abbott Laboratories,). A crossover study showed an excellent correlation between the 2 Hcy methods (n ¼ 361; r 2 ¼ 0.9817) (14) . Folate and cobalamin concentrations in serum and RBC folate in whole blood hemolysate sample were measured using Quantaphase II radioassay kit (Bio-Rad Laboratories). Serum MMA was measured using GC/MS. Serum creatinine was measured using an autoanalyzer (Hitachi Model 917 for NHANES 1999-2002; Beckman Synchron LX20 for NHANES [2003] [2004] . Serum cotinine was measured using isotope dilution-HPLC/ atmospheric pressure chemical ionization tandem MS. The detailed methodology on laboratory procedures is described elsewhere (40) (41) (42) .
BP was measured using a mercury sphygmomanometer (W A Baum) according to the standardized protocol recommended by the AHA (43) . Individuals who took vitamin/mineral supplements 1 mo before the survey were categorized as supplement users. Serum cotinine was used as a measure of intensity of smoking. Serum cotinine concentration was correlated with the number of cigarettes smoked (44) . Sex, race/ethnicity, age, BMI, systolic BP, diastolic BP, vitamin/mineral supplement use, RBC folate, and concentrations of serum creatinine, cotinine, folate, cobalamin, and MMA were selected as potential variables that would be related to plasma tHcy concentrations in the post-folic acid fortification period.
Statistical analysis. SUDAAN statistical software (SUDAAN for Windows, version 8.0.2, Research Triangle Institute) was used to account for complex survey design. In data analysis, sample weights, primary sampling units, and stratification variables were considered to account for differential probabilities of selection and adjustments for noncoverage and nonresponse bias per the NCHS guidelines. Also, we used SAS (SAS for Windows, version 8.0, SAS Institute) in conjunction with SUDAAN to manage and analyze data files.
In the NHANES 1999-2004, individuals aged .85 y were categorized as 85 y to protect the confidentiality of survey participants. These individuals were excluded from the analysis so that age could be used as a continuous variable. Because of nonnormality distribution of plasma tHcy, natural logarithmic transformation was used in the analysis to satisfy the requirement for normality. Standard errors were estimated with Taylor Linearization method, which takes NHANES complex survey design into consideration.
The significant difference between men and women in selected characteristics was determined with 2-tailed t tests. We used multivariate linear regression to evaluate the simultaneous effects of selected predictors of plasma tHcy on plasma tHcy. Plasma tHcy concentrations were determined for sex, race/ethnicity, age, BMI, systolic and diastolic BP, supplement use, serum and RBC folates, and serum cotinine, creatinine, cobalamin, and MMA variables. All continuous predictor variables except age were divided into quartile cutoff points. Quartile groups within the variable did not yield equal sample size because of the specific cutoff values used in defining the 25th, 50th, and 75th percentiles for the described variable. Age was classified into 4 categories: ,20 y, 20 to ,40 y, 40 to ,60 y, and $60 y. We used ANCOVA to determine the sex-, race/ethnicity-, and age-adjusted and multivariate-adjusted means for plasma tHcy concentrations. A pairwise comparison between categories within the variable was made using a 2-tailed, unpaired t test after testing the hypothesis with ANCOVA.
Additionally, we performed a multivariate regression analysis between plasma tHcy and continuous variables (age, BMI, systolic and diastolic BP, serum and RBC folates, and serum cobalamin, MMA, cotinine, and creatinine,). Because of the lack of causal relation between tHcy and MMA, 2 multivariate regression models were constructed, one with serum cobalamin but without serum MMA and the other with serum MMA but without serum cobalamin. We also calculated Pearson correlation coefficients between plasma tHcy and continuous variables. Significance was set at P , 0.05.
Results
Characteristics of the study population are presented ( Table 1 ). The study sample consisted of ;51% men, ;49% women, ;43% NHW, ;24% NHB, and ;33% MA/H. More women than men consumed vitamin/mineral supplements. Based on serum cotinine concentrations, more men than women were categorized as smokers. Women were slightly but significantly older than men. BMI did not differ between the sexes. Systolic and diastolic BP and concentrations of serum creatinine and cotinine were significantly higher in men than in women and concentrations of serum and RBC folates and serum cobalamin were significantly higher in women than in men. Serum MMA concentrations did not differ between women and men.
Unadjusted and multivariate-adjusted plasma tHcy concentrations for sex, age, and race/ethnicity are presented ( Table 2) . Unadjusted plasma tHcy was ;18.4% higher in men than in women. After adjustment for several covariates, the tHcy was ;9.7% higher in men than in women. Multivariate-adjusted tHcy was higher (;5.0%) in NHW than in NHB and MA/H, but NHB and MA/H did not differ in plasma tHcy. Age was significantly associated with plasma tHcy in both unadjusted and multivariate-adjusted models. Multivariate-adjusted plasma tHcy was ;22.9% higher in individuals aged 20 to ,40 y, ;38.5% higher in individuals aged 40 to ,60 y, and ;64.5% higher in individuals aged $60 y than in individuals aged ,20 y.
Associations between plasma tHcy and health and lifestyle factors are presented ( Table 3) . Multivariate-adjusted plasma tHcy was directly related to systolic BP (r ¼ 0.22; P , 0.0001), serum creatinine (r ¼ 0.32; P , 0.0001), and serum cotinine (r ¼ 0.12; P , 0.0001). Persons in the 4th quartile group for systolic BP, serum creatinine, and cotinine had ;5.6, ;36.1, and ;11.2%, respectively, higher plasma tHcy than those in the 1st quartile group. Persons who reported supplements use had ;5% lower plasma tHcy than those who did not report use of supplements. In the multivariate-adjusted analysis, plasma tHcy was not significantly related to BMI and diastolic BP.
Associations between plasma tHcy and blood concentrations of B vitamins and MMA are presented ( Table 4) . Plasma tHcy was 
1 Values are means 6 SEM or n (%). 2 Significance for the t-statistic between men and women (a 2-tailed t test). 3 Persons with serum cotinine concentrations $79.5 nmol/L were classified as smokers. 
Discussion
To date, this is the most comprehensive report on the population determinants of plasma tHcy concentrations in the post-folic acid fortification era. In this study, we report modifiers of plasma tHcy concentrations in a nationally representative sample utilizing the data from 3 NHANES cycles conducted in the post-folic acid fortification period. Concatenating the 3 surveys into 1 analytic data file resulted in a large sample size that not only allowed us to use several covariates in the regression modeling but also increased the precision of the estimate. In the post-folic acid fortification period, sex, age, race, supplement use, RBC folate, and serum creatinine, cotinine, folate, and cobalamin were significant determinants of plasma tHcy. Among all continuous variables examined, serum MMA showed the strongest association with plasma tHcy. Serum folate was a weak determinant of tHcy. Multivariate-adjusted plasma tHcy was ;0.73 mmol/L greater in men than in women. Given the differences in folate and cobalamin status, vitamin/mineral supplements use, and serum creatinine and cotinine concentrations between men and women, it was expected that men would have higher tHcy than women. After adjustment for these variables, the difference in tHcy between men and women persisted, suggesting metabolic causes for the differences in tHcy between men and women. In men, the renal cystathionine b synthase activity is significantly lower than in women, leading to higher tHcy. The renal cystathinone synthase is a testosterone-dependant enzyme that converts Hcy to cysteine in transsulfuration pathway (45) .
Age is a significant determinant of plasma tHcy in the postfortification period after considering several covariates in the multivariate model. The tHcy concentrations are significantly lower across the age groups in the postfortification period compared with the prefortification period (27) . The extent of decrease in circulating tHcy from pre-to postfortification period is by and large similar across the age groups. For example, in the prefortification period (NHANES 1988 (NHANES -1994 , tHcy concentrations were 9.1, 9.4, 10.8, and 12.5 mmol/L in ,30 y, 30-50 y, 50-70 y, and $70 y olds, respectively (27) , whereas in this study, tHcy concentrations were 6.2, 7.3, 8.3, and 9.7 mmol/L in ,20 y, 20-40 y, 40-60 y, and $60 y age groups, respectively. Due to methodological differences between NHANES 1988-1994 and NHANES 19991, caution should be used in comparing the data across the NHANES. In this study, plasma tHcy in the $60-y-old age group was ;3.5 mmol/L greater than in the ,20-y-old age group. Age-related increase in tHcy is unrelated to folate status, because serum folate and RBC folates are significantly higher in older persons compared with younger persons (7). Age-related increase in circulating tHcy is due to multiple causes. These include age-dependent decrease in enzymes that metabolize Hcy (46) , declined renal function (47) , and increased cobalamin deficiency due to malabsorption of cobalamin by the aging gut (48) .
In the postfortification period, race/ethnicity was a significant determinant of plasma tHcy. Although the folic acid fortification resulted in a significant increase in folate status (7) (8) (9) (10) (11) and decrease in tHcy (7, 9, 14) , race/ethnicity disparities exist in plasma tHcy concentrations in the US. In this study, multivariateadjusted plasma tHcy was significantly higher (5.3% or ;0.4 mmol/L) in NHW than in NHB. This is despite higher folate status in NHW compared with NHB (7). This can be explained by lower serum cobalamin concentrations and an increased prevalence of MTHFR polymorphism in NHW than in NHB. Additional analysis on this current study data revealed that sex-and age-adjusted serum cobalamin concentrations were 1 Values are means 6 SEM. Because plasma tHcy concentrations were not normally distributed, natural logarithmic transformation was used to satisfy the normality requirement. 2 Significance when compared with the reference group within the variable. A pairwise comparison was made with a 2-tailed t test after testing the hypothesis with ANCOVA. 3 Significance for the effect of sex-, race/ethnicity-, and age-adjusted variable on tHcy in ANCOVA. 4 Adjusted for sex, race/ethnicity, age, BMI, systolic and diastolic BP, supplement use, serum and RBC folates, and serum cobalamin, creatinine, cotinine, and MMA in ANCOVA. 5 Significance for the effect of multivariate-adjusted variable in tHcy in ANCOVA. 6 Continuous variable, categorized by quartiles. 7 Used as a referent group for comparison within the variable.
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by guest on October 14, 2017 jn.nutrition.org significantly lower in NHW (369 pmol/L) than in NHB (430 pmol/L; P , 0.0001). Similar to our finding, Stabler et al. (49) previously reported significantly lower cobalamin concentrations in white women than in black women. Because cobalamin is a coenzyme for methionine synthase (required for remethylation of Hcy to methionine), an inverse association between serum cobalamin and tHcy concentrations is expected. Mutation in the MTHFR gene (677C/T) results in reduced activity of MTHFR, especially in those with low folate status. MTHFR activity is reduced to 34% in TT and 71% in CT relative to wildtype CC (50) . MTHFR converts N 5 N 10 methylenetetrahydrofolate to 5-methyltetrahydrofolate, which is a methyl donor for remethylation of Hcy to methionine. Persons with homozygosity for 677C/T (TT) (present in ;12% NHW) have increased circulating tHcy concentrations (20) and have a greater requirement for folate compared with those with the CT or CC genotype (51) . Because folate status has dramatically improved in the post-folic acid fortification period (7) (8) (9) (10) (11) , the impact of MTHFR polymorphism on tHcy would be reduced in the postfortification era.
In this study, plasma tHcy and cotinine, a biochemical marker of smoking, were directly related in the post-folic acid fortification period. There was a similar relationship between cotinine and tHcy in the pre-folic acid fortification period (NHANES 1988 (NHANES -1994 ) (P ¼ 0.0001) (27) , suggesting that the association between cotinine and tHcy is not modified as a result of folic acid fortification. Serum cotinine is a reliable biochemical marker of smoking, because self-reported smoking is often underreported (52) . Also, serum cotinine accounts for second-hand smoking. In this study, persons who are in the 4th quartile for serum cotinine had ;0.84 mmol/L higher plasma tHcy than those in the first quartile. Although the exact mechanism through which cotinine influences tHcy is not known, the likely explanation for high tHcy in smokers is low folate, cobalamin, and pyridoxine status (53) (54) (55) and decreased activity of methionine synthase (56, 57) .
Systolic BP was a significant determinant of plasma tHcy in the postfortification period. Persons with $129 mm Hg systolic BP had ;0.57 mmol/L higher tHcy than did persons with systolic BP ,108 mm Hg. These results support the previously reported direct relation between tHcy and BP in the Hordaland Homocysteine Study by Refsum et al. (16) . Rasmussen et al. (33) found a direct relation between systolic BP and tHcy in younger subjects. However, it is not known exactly whether increased tHcy leads to increased BP or increased BP leads to increased tHcy concentrations.
Inverse associations between serum folate, RBC folate, and serum cobalamin and tHcy concentrations reported in this study are in accordance with earlier studies using the data collected in the prefortification period (26, 27) . Earlier, we reported that folic acid fortification resulted in a 130-150% increase in mean serum folate concentrations and decreased prevalence of low serum folate from 18.4 to 0.2% from pre-to postfortification period in the US (7). In Canada, folic acid fortification improved serum folate by ;51-67% (58) . Given the dramatic increase in folate status in the postfortification era, the decrease in plasma tHcy is anticipated. In this study, persons in the first quartile for serum folate had ;1.4 mmol/L higher tHcy compared with those in the 4th quartile. However, the inverse association between serum folate and tHcy was weak, albeit significant. Quinlivan et al. (59) reported that dependency of tHcy on folic acid gradually diminished in women when they received sequential supplementation of 100, 200, and 400 mg/d of folic acid. Folic acid fortification resulted in an increased intake of .200 mg/d of folic acid (4) . Thus, the weakened relation between serum folate and plasma tHcy in this study was likely due to improved folate status from the mandated folic acid fortification. Because of this improved folate status in the postfortification period (7-11), low cobalamin status has emerged as the dominant determinant of circulating tHcy (60, 61) . Liaugaudas et al. (60) reported that population-attributable risk percentages for hyperhomocysteinemia were 1% for serum folate , 5 mg/L (11.33 nmol/L) and 24.5% for serum cobalamin , 250 pg/mL (184.5 pmol/L) in patients with stable coronary artery disease. Similarly, in the Sacramento Latino Study (61) , the population-attributable risk percentages for hyperhomocysteinemia were 29.7% for serum cobalamin , 148 pmol/L and 0.3% for RBC folate , 365 nmol/L in subjects aged $60 y.
To our knowledge, this is the first study to report a direct relation between serum MMA and plasma tHcy in a nationally representative sample that supports the previous observation in a convenience sample by Koehler et al. (62) . MMA is considered a sensitive marker of cobalamin deficiency. In cobalamin deficiency, MMA is derived from the hydrolysis of methylmalonylCoA due to decreased function of cobalamin-dependant methylmalonyl-CoA mutase, which converts methylmalonylCoA to succinyl-CoA (63) . Both tHcy and MMA are elevated in cobalamin deficiency. The severity of cobalamin deficiency is associated with increased circulating MMA and tHcy (64) . However, serum MMA is not a gold standard for cobalamin deficiency, because a significant number of elderly persons with high cobalamin status had high MMA concentrations. This was likely due to declined renal function rather than true cobalamin deficiency (64) . Because of stronger association between serum MMA and plasma tHcy in the post-folic acid fortification period, screening for cobalamin deficiency is important, especially in older persons who are at risk for cobalamin deficiency.
Due to the cross-sectional nature of this study, assessment of cause and effect relation was not possible. Because plasma tHcy concentrations have changed inversely in response to changes in serum folate concentrations (7, (9) (10) (11) , plasma tHcy can be used as a biochemical marker in assessing the impact of folic acid fortification at population level. In the US, plasma tHcy concentrations have declined by 8-10% in men and by 3-13% in women as a result of mandated folic acid fortification (14) . If elevated tHcy is associated with increased risk for CVD, then the decreased tHcy would have an opposite effect on CVD. So far, the controlled trials addressing this question have yielded some positive results (65). Yang et al. (66) reported that the stroke mortality has declined from the pre-to postfortification period in the US and Canada. Because of the rise and fall of serum folate concentrations after folic acid fortification, it is important to monitor the impact of nationwide mandated folic acid fortification on overall health and well being of U.S. residents on a continuous basis.
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